Chronic Granulomatous Disease (CGD)
Overview
Chronic Granulomatous Disease (CGD) is a rare, inherited primary immunodeficiency in which phagocytes (neutrophils, monocytes, and macrophages) are unable to produce a normal respiratory burst of reactive oxygen species. This defect impairs the body’s ability to kill certain bacteria and fungi, leading to recurrent, often severe, infections and the formation of granulomas (clusters of immune cells) in various organs.[1][2]
CGD is most commonly X‑linked (mutations in the CYBB gene) but can also be autosomal recessive (mutations in NCF1, NCF2, NCF4). The disease usually presents in early childhood, but milder forms may not be diagnosed until adolescence or adulthood.[3]
Symptoms Checklist
Typical manifestations are related to infections and granuloma formation. Use the checklist below to track symptoms that may suggest CGD.
- ☐ Recurrent skin abscesses (often caused by Staphylococcus aureus)
- ☐ Persistent pneumonia or lung infections
- ☐ Suppurative lymphadenitis (painful swollen lymph nodes)
- ☐ Hepatic or splenic abscesses
- ☐ Gastrointestinal inflammation (colitis, granulomatous bowel disease)
- ☐ Osteomyelitis (bone infection) especially in the ribs or long bones
- ☐ Chronic or recurrent fungal infections (e.g., Aspergillus)
- ☐ Granuloma formation causing obstruction (e.g., urinary tract, gastrointestinal tract)
- ☐ Fever of unknown origin
- ☐ Poor wound healing after trauma or surgery
Note: The severity and combination of symptoms vary widely among individuals.[2][4]
Risk Factors
- Genetic inheritance: X‑linked CGD affects males; autosomal recessive forms affect both sexes.
- Family history: Having a sibling or parent with CGD increases risk.
- Ethnicity: Certain mutations are more prevalent in specific populations (e.g., X‑linked CGD is more common in Caucasian males).
- Consanguinity: Marriages between close relatives raise the chance of autosomal recessive CGD.
Diagnosis
Diagnosis combines clinical suspicion with specialized laboratory testing:
- Dihydrorhodamine (DHR) flow cytometry test: Measures the oxidative burst of neutrophils; the gold‑standard screening test.[5]
- NBT (nitroblue tetrazolium) test: Older qualitative assay; less commonly used now.
- Genetic testing: Sequencing of CYBB, NCF1, NCF2, NCF4 to confirm the specific mutation.
- Imaging & microbiology: CT, MRI, or ultrasound to locate abscesses; cultures to identify causative organisms.
- Immunologic work‑up: Complete blood count, immunoglobulin levels, and assessment for other immune defects.
Referral to a clinical immunologist or a center specializing in primary immunodeficiencies is recommended for definitive diagnosis.[1][3]
Treatment Options
Management aims to prevent infections, treat active infections promptly, and modulate the immune response.
Medical Therapies
- Prophylactic antibiotics: Trimethoprim‑sulfamethoxazole (TMP‑SMX) reduces bacterial infections.[2]
- Antifungal prophylaxis: Itraconazole or posaconazole to prevent Aspergillus and other fungi.[2]
- Interferon‑γ (IFN‑γ) therapy: Improves oxidative burst in some patients; given 3 times weekly.[4]
- Prompt aggressive treatment of acute infections: Broad‑spectrum IV antibiotics, surgical drainage of abscesses when needed.
- Hematopoietic stem cell transplantation (HSCT): The only curative option for many patients; success rates improve with matched donors and reduced‑intensity conditioning.[3]
- Gene therapy (investational):** Ongoing clinical trials using lentiviral vectors to correct the defective gene.
Home & Supportive Care
- Maintain up‑to‑date immunizations (avoid live vaccines unless specifically approved).
- Practice meticulous wound care; clean cuts promptly and keep them covered.
- Use a high‑efficiency particulate air (HEPA) filter at home if fungal exposure is a concern.
- Regular dental check‑ups to prevent oral infections.
- Vaccinate household contacts against influenza and pneumococcus to reduce transmission.
Prevention
- Genetic counseling: Families with a known mutation should receive counseling before future pregnancies.
- Prophylactic medication adherence: Daily TMP‑SMX and weekly antifungal agents dramatically lower infection rates.
- Environmental precautions: Avoid exposure to soil, mulch, construction dust, and bird droppings—common sources of Aspergillus.
- Prompt treatment of minor infections: Early antibiotics can prevent progression to severe disease.
- Regular follow‑up: Quarterly visits with an immunologist to monitor labs and adjust therapy.
Living With Chronic Granulomatous Disease
While CGD is a lifelong condition, many patients lead active, fulfilling lives with proper management.
- Education & school: Inform teachers and school nurses about the condition and emergency plan.
- Physical activity: Encourage regular exercise but avoid high‑risk activities that may cause deep skin punctures or severe trauma.
- Nutrition: A balanced diet supports overall immunity; consider a dietitian if gastrointestinal granulomas affect absorption.
- Psychosocial support: Join patient advocacy groups (e.g., CGD Foundation) for peer support and up‑to‑date resources.
- Travel considerations: Research medical facilities at destination, carry a medical alert card, and bring an extra supply of prophylactic meds.
- Medication management: Use a pill organizer and set alarms to ensure daily and weekly prophylaxis are not missed.
When to Seek Emergency Care
Immediate medical attention is required for any of the following:
- High‑grade fever (> 101.5 °F / 38.6 °C) lasting > 24 hours.
- Rapidly enlarging or painful swelling (possible abscess) especially in the abdomen, chest, or limbs.
- Severe shortness of breath, chest pain, or coughing up blood.
- Sudden onset of severe abdominal pain, vomiting, or signs of intestinal obstruction.
- Neurological changes (confusion, severe headache, seizures) suggesting CNS infection.
- Uncontrolled bleeding from a wound or after surgery.
- Any sign of a serious fungal infection (e.g., sinus pain with black discharge, persistent cough with sputum).
Call emergency services (911 in the U.S.) or go to the nearest emergency department. Inform the staff that the patient has CGD and is on prophylactic antibiotics/antifungals.
Medical Disclaimer: This guide is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized care. The content reflects current knowledge as of the publication date and may not include the latest research developments.
References
- Mayo Clinic. “Chronic granulomatous disease.” https://www.mayoclinic.org.
- National Institutes of Health (NIH) – GeneReviews. “Chronic Granulomatous Disease.” https://www.ncbi.nlm.nih.gov.
- Johns Hopkins Medicine. “Chronic Granulomatous Disease (CGD).” https://www.hopkinsmedicine.org.
- Cleveland Clinic. “Chronic Granulomatous Disease.” https://my.clevelandclinic.org.
- Centers for Disease Control and Prevention (CDC). “Primary Immunodeficiency Diseases – Chronic Granulomatous Disease.” https://www.cdc.gov.